제품 수집
제품 세부정보
Synonyms
CD28, Tp44
Source
Mouse CD28, Fc Tag (CD8-M5258) is expressed from human 293 cells (HEK293). It contains AA Asn 20 - Lys 149 (Accession # P31041-1).
Predicted N-terminus: Asn 20
Request for sequenceMolecular Characterization
Other Tags and Version Biotin & Other Labeled Version
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 41.5 kDa. The protein migrates as 55-60 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
고객님도 확인한 상품
데이터 표시
SDS-PAGE
Mouse CD28, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS
The purity of Mouse CD28, Fc Tag (Cat. No. CD8-M5258) is more than 95% and the molecular weight of this protein is around 95-115 kDa verified by SEC-MALS.
Report
Bioactivity-BLI
Loaded Mouse CD28, Fc Tag (Cat. No. CD8-M5258) on Protein A Biosensor, can bind Mouse B7-2, His Tag (Cat. No. CD6-M52H0) with an affinity constant of 7.9 μM as determined in BLI assay (ForteBio Octet Red96e) (QC tested).
Protocol
Loaded Mouse CD28, Fc Tag (Cat. No. CD8-M5258) on Protein A Biosensor, can bind Mouse B7-1, His Tag (Cat. No. CD0-M5228) with an affinity constant of 8.1 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Protocol
사용자 리뷰 댓글 남기기
배경 소개
프론티어 진행
의약품 개발 진행- 영어 이름：
T-cell-specific surface glycoprotein CD28
- 카테고리：
- 상장 의약품 수：
0 상세
- 임상 의약품 수：
31 상세
- 최고 개발 단계：
Phase 2 Clinical
연락하기
전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
신약 후보물질 라이선싱
